1. Role of biological response modifiers in the treatment of tumors

   • Peter Reizenstein

   Editorial Pages: 1 - 1

2. Thymomodulin: biological properties and clinical applications

   • N. M. Kouttab
   • M. Prada
   • P. Cazzola

   OriginalPaper Pages: 5 - 9

3. Therapy of secondary T-cell immunodeficiencies with biological substances and drugs

   • John W. Hadden
   • Elba M. Hadden

   OriginalPaper Pages: 11 - 17

4. Immunomodulation with thymopentin:in vitro studies

   • J. Duchateau
   • K. Bolla

   OriginalPaper Pages: 19 - 23

5. Thymulin, a zinc-dependent hormone

   • Jean-François Bach
   • Mireille Dardenne

   OriginalPaper Pages: 25 - 29

6. Therapeutic application of calf thymus extract (TFX)

   • Aleksander B. Skotnicki

   OriginalPaper Pages: 31 - 43

7. Modulation of NK activity by thymic hormones:in vitro effects of thymostimulin

   • Anna Marina Liberati
   • Saverio Cinieri
   • Lucia Palmisano

   OriginalPaper Pages: 45 - 52

8. Preliminary results on clinical and immunological effects of thymus hormone preparations in AIDS

   • Philippe Hermans
   • Nathan Clumeck

   OriginalPaper Pages: 55 - 58

9. Effect of the immunomodulator LF 1695 on T-lymphocytes and macrophages. Activity in HIV infection

   • Jean-Louis Touraine

   OriginalPaper Pages: 59 - 61

10. Clinical and immunological assessment in HIV+ subjects receiving inosine-pranobex. A randomised, multicentric study

    • C. De Simone
    • F. Albertini
    • V. Vullo

    OriginalPaper Pages: 63 - 67

11. 4′-O-Tetrahydropyranyl adriamycin (THP-ADM)-induced modifications of murine peritoneal macrophages

    • A. Bravo-Cuellar
    • G. Mathé
    • S. Orbach-Arbouys

    OriginalPaper Pages: 71 - 75

12. Cyclophosphamide and melphalan as immunopotentiating agents in cancer therapy

    • Sheldon Dray
    • Margalit B. Mokyr

    OriginalPaper Pages: 77 - 85

13. Clinical evaluation of treatment with interferon

    • Hans Strander

    OriginalPaper Pages: 87 - 91

14. Cytotoxicity and clinical application of activated NK cells

    • Eva Lotzová

    OriginalPaper Pages: 93 - 98

15. The clinical use of monoclonal antibodies, MAb 17-1A, in the treatment of patients with metastatic colorectal carcinoma

    • H. Mellstedt
    • J. E. Frödin
    • R. Erwald

    OriginalPaper Pages: 99 - 107

16. Cimetidine as an immune response modifier

    • Robert Hast
    • Per Bernell
    • Mona Hansson

    OriginalPaper Pages: 111 - 113

17. Postgraduate course on Markers of Tumor Progression 13 April 1989

    Announcement Pages: 115 - 115